Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$23,039,178
-$7,983,862 QoQ
Shares Held
36,949
-8.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#196
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Jun 30, 2020CallValue
$10,000
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $452,608,635 across 219 Biotechnology names. REGN ranks #2 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in REGN
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,039,178 | 36,949 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $31,023,040 | 40,152 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $23,259,529 | 30,134 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,211,100 | 19,939 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,979,625 | 9,485 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $7,209,292 | 11,367 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,235,848 | 10,158 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $12,397,272 | 11,793 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $10,105,650 | 9,615 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $8,300,512 | 8,624 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,226,197 | 7,089 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,487,496 | 6,668 | Shares | Defined | 2023-11-16 | |
| 2023-06-30 | $4,395,308 | 6,117 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $4,738,570 | 5,767 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,695,471 | 5,122 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,024,828 | 4,391 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $2,319,594 | 3,924 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,885,035 | 2,699 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,720,260 | 2,724 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,485,111 | 2,454 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,669,476 | 2,989 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,983,620 | 6,306 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $2,369,654 | 4,905 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $2,414,890 | 4,314 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $10,000 | 100 | Call | Sole | 2020-07-23 | |
| 2020-06-30 | $2,313,117 | 3,709 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $2,022,497 | 4,142 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||